Myriad Genetics (STU:MYD) Inventory Turnover: 2.16 (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Myriad Genetics Inc STU:MYD

54 GF Score

Price €5.26

GF Value €13.22

Valuation Possible Value Trap

5 Warning Signs

View Full Analysis

What is Myriad Genetics Inventory Turnover?

Myriad Genetics STU:MYD +2.37% 54 Inventory Turnover is 2.16 as of Mar. 2026. GuruFocus rates STU:MYD with a GF Score™ of 54/100 and a GF Value™ of €13.22 (Possible Value Trap). The stock has 5 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Myriad Genetics's Cost of Goods Sold for the three months ended in Mar. 2026 was €54.3 Mil. Myriad Genetics's Average Total Inventories for the quarter that ended in Mar. 2026 was €25.1 Mil. Myriad Genetics's Inventory Turnover for the quarter that ended in Mar. 2026 was 2.16.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Myriad Genetics's Days Inventory for the three months ended in Mar. 2026 was 42.22.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Myriad Genetics's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.14.

Myriad Genetics (STU:MYD) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Myriad Genetics's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	25.1325	/	54.322	*	365 / 4
	=	42.22

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Myriad Genetics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	25.1325	/	173.346
	=	0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Myriad Genetics Inventory Turnover Related Terms

Myriad Genetics Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Myriad Genetics's Inventory Turnover can be seen below:

Myriad Genetics Inventory Turnover Chart

Myriad Genetics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

8.88

11.73

11.07

10.37

8.08

Myriad Genetics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															2.18	2.08	2.04	2.03	2.16

54GF Score

Myriad Genetics Inc STU:MYD

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Myriad Genetics Inventory Turnover Calculation

Myriad Genetics's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	211.707	/ (	(26.263	+	26.132)	/	2 )
=	211.707	/	26.1975
=	8.08

Myriad Genetics's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	54.322	/ (	(26.132	+	24.133)	/	2 )
=	54.322	/	25.1325
=	2.16

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 2.16 mean?

Myriad Genetics (STU:MYD) has a Inventory Turnover of 2.16 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Myriad Genetics and its competitors.

Is Myriad Genetics' Inventory Turnover too high?

Myriad Genetics' current Inventory Turnover is 2.16. Overall, Myriad Genetics has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Myriad Genetics' Inventory Turnover compare to FLGT and CSTL?

Myriad Genetics' Inventory Turnover of 2.16 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Diagnostics & Research company?

A good Inventory Turnover depends on the Medical Diagnostics & Research industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Myriad Genetics and its competitors. Myriad Genetics's current Inventory Turnover is 2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Myriad Genetics stock overvalued right now?

Based on GuruFocus' analysis, Myriad Genetics (STU:MYD) is currently considered Possible Value Trap. The stock's GF Value™ is €13.22, compared to a current price of €5.26 — trading 60.2% below its estimated fair value. The current Inventory Turnover is 2.16. Myriad Genetics' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Myriad Genetics (STU:MYD), the current Inventory Turnover is 2.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Myriad Genetics (STU:MYD) Overvalued in 2026?

Based on GuruFocus' analysis, Myriad Genetics stock appears to be undervalued. The current stock price of €5.26 is trading 60.2% below its estimated GF Value™ of €13.22. GuruFocus considers Myriad Genetics to be Possible Value Trap.

Key valuation signals for STU:MYD:

Inventory Turnover: 2.16
GF Value™: €13.22 vs. price of €5.26 (60.2% below fair value)
GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the STU:MYD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Myriad Genetics Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies FLGT CSTL BDSX IMDX XGN BNR IDXG PRPO QUCY BIOQ TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN

Other Exchanges MYGN:USA 0K3W:UK MYD:Germany

Address 322 North 2200 West, Salt Lake City, UT, USA, 84116

Website https://www.myriad.com

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

54GF Score

Get the complete analysis for STU:MYD

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.26

Price

€13.22

GF Value

View STU:MYD Analysis

See Inventory Turnover data for all stocks →